Retrospective Chart Review and Historical Comparison of Capmatinib vs. Standard of Care for German Adult Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring METex14 Mutations
Clinical trial NCT05796726 · COMPLETED
Trial details
- NCT number
- NCT05796726
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-10
- Primary completion
- 2022-03-22
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.